Renub Research latest report “Radiofrequency Based Devices Market, Global Forecast By Product (Capital Equipment, Disposable Equipment & Reusable Equipment), Application (Oncology, Cardiology, Cosmetic Surgery, Gynaecology & Others), End-User (Hospitals, Ambulatory Surgical Centers &Others), Region (North America, Europe, Asia Pacific, Latin America and Middle East Africa), Company Analysis 2022-2028″ finds that the Radiofrequency Ablation Devices Market size is projected to reach US$ 8.18 Billion by 2030.
Radiofrequency Based Devices observe thermal power to tissue by utilizing an electrosurgical generator that is linked to bipolar electrode arrays. The radiofrequency range of 450 to 500 kHz is used to transmit power through the tissue between high quality and negative poles positioned alongside the electrode arrays of the RFA tool.
The development in RF ablation technology is set to create superior and accurate devices. These devices can target unique tissues, tumors, or nerves with brilliant precision, even as minimizing damage to surrounding healthy tissues. This better level of accuracy has brought about higher treatment effects and decreased the probability of headaches. Additionally, the smaller size of RF ablation devices and the introduction of greater bendy and maneuverable catheters make it less complicated for healthcare companies to access tough anatomical places, carry out complex processes, and beautify affected person consolation at some stage in therapy.
Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=radiofrequency-based-devices-market-p.php
Moreover, the combination of RF ablation devices with superior medical imaging technology which includes ultrasound, CT scans, and MRI allows actual-time visualization of the treatment area, improving accuracy and imparting on the spot comments to the medical group for the duration of the procedure. Additionally, RF ablation devices offer multi treatment modalities, combining radiofrequency strength with different strategies, together with microwave or cryoablation, for precise disease treatment.
Radiofrequency Ablation Devices Market is predicted to grow at a CAGR of 10.50% throughout the forecast duration of 2022-2030
Radiofrequency ablation (RFA) makes use of warmness to destroy tissue. Radio waves are sent via an exactly positioned needle to warmness a nerve place for pain control. This prevents pain signals from being sent returned in mind. RFA is taken into consideration for long term condition pain situations, mainly neck, lower back, or arthritic joints that have not been successfully with different techniques.
The radiofrequency ablation devices market is witnessing an increase in market revenue owing of the rising incidence of various chronic illnesses, inclusive of cardiovascular diseases. According to World Health Organization (2023), cardiovascular diseases (CVDs) are the leading cause of loss of life throughout the globe, where this group of diseases disorders for an estimated 17.9 million lives every year.
CVDs are classified as a group of disorders that specifically affect the heart and blood vessels. Some CVDs consist of coronary heart disease, rheumatic heart ailment, cerebrovascular disease, and different conditions. Additionally, World Heart Foundation stated that by 2030, almost 14–17 million humans in the European Union might be residing with atrial traumatic inflammation and the supply further noted that the numbers for atrial fibrillation reached 12 million in the United States.
Radiofrequency ablation is a famous technique that’s employed within the AFib treatment. Therefore, the rising worldwide prevalence of cardiovascular diseases inclusive of atrial fibrillation could surge the demand for radiofrequency ablation devices, thereby aiding within the global radiofrequency ablation devices marketplace increase.
Another key aspect responsible for the radiofrequency ablation devices market increase is the growing prevalence of numerous cancers. Liver cancers are one of the unusual kinds of cancers where radiofrequency ablation is used as one of the treatment methods. According the GLOBOCAN, in 2020, there were approximately 905,677 new cases and approximately 830,108 deaths associated with liver cancer respectively throughout the globe. Even though radiofrequency ablation isn’t the mainstay treatment for cancers, it’s miles regularly used as both an adjunctive medication or is recommended on a case-to-case foundation. Therefore, the rising prevalence of cancers of different etiologies is likewise anticipated to make a contribution to the developing demand for radiofrequency ablation devices, transferring the market forward during the forecast period.
North America accounted for the largest revenue share.
Among all of the regions, North America is anticipated to account for a great market proportion within the radiofrequency ablation devices market. North America is anticipated to account for the dominant market percentage because of the high occurrence of persistent pain from various motives such as low lower back pain, neck pain, and arthritis, amongst different elements, the growing populace of growing old in addition to excessive cognizance amongst people regarding disease management and the new product launches inside the North American region.
Product – Breakup Covered from 3 viewpoints:
1. Capital Equipment
2. Disposable Equipment
3. Reusable Equipment
Application – Breakup Covered from 5 viewpoints:
1. Oncology
2. Cardiology
3. Cosmetic Surgery
4. Gynecology
5. Others
End User – Breakup Covered from 3 viewpoints:
1. Hospitals
2. Ambulatory Surgical Centers
3. Others
Region – Breakup Covered from 5 viewpoints:
1. North America
1.1 United States
1.2 Canada
2. Latin America
2.1 Mexico
2.2 Brazil
3. Europe
3.1 United Kingdom
3.2 Germany
3.3 France
3.4 Italy
3.5 Spain
3.6 Netherlands
4. Asia Pacific
4.1 China
4.2 Japan
4.3 India
4.4 South Korea
4.5 Australia
5. Middle East & Africa
5.1 United Arab Emirates
5.2 South Africa
6. Rest of the World
Company Insights:
• Overview
• Recent Development
• Revenue
Key Players:
1. Boston Scientific Corporation Inc
2. Abbott Laboratories
3. AtriCureInc
4. Medtronic Plc
5. Stryker
6. Smith & Nephew Plc
7. Conmed Corporation
8. HologicInc
About the Company:
Renub Research is a Market Research and Consulting Company. We have more than 15 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemical, Logistics Automotive, Consumer Goods Retail, Building, and Construction, Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.
Contact Us:
Renub Research
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Email: info@renub.com
LinkedIn: https://in.linkedin.com/company/renub-research
Web: www.renub.com
